The Empty Vials: Kenya’s vaccine crisis is a global equity failure

Until the cold chain is full, no health system in the Global South is truly secure.

By the Editorial Board | Ethical Business

The sight of empty vaccine refrigerators in Kenyan clinics is a visceral symbol of broken promises. When the country faced catastrophic shortages of essential childhood vaccines – BCG, Polio, Measles-Rubella – reaching critical lows in mid-2025 and completely depleting stocks in 12 counties, it was not merely a local logistical hiccup. It was a stark, undeniable manifestation of the systemic inequities crippling global health and a direct assault on the ambitions of Sustainable Development Goals 3 (Good Health and Well-being) and 10 (Reduced Inequalities). Kenya’s crisis is not an anomaly; it is the predictable outcome of a global system designed to fail the Global South.

Structural Barriers: The Roots of Inequity

The barriers preventing consistent vaccine access in low- and middle-income countries (LMICs) are deeply entrenched and mutually reinforcing:

1. Chronic Funding Shortfalls: Reliance on volatile donor funding and insufficient domestic health budgets creates fragile systems. Kenya’s emergency scramble for KSh 1.25 billion highlights this vulnerability. Sustainable financing for routine immunization is often sacrificed, leaving countries perpetually on the brink, directly undermining SDG 3’s target for universal health coverage and access to essential medicines.
2. Global Supply Bottlenecks & Market Failures: Vaccine production remains concentrated in a handful of high-income nations. Supply chains prioritize profitable markets, leaving LMICs at the back of the queue for both routine and outbreak vaccines. This artificial scarcity is a core driver of SDG 10’s global inequality – where you live determines if your child gets a life-saving jab.
3. Donor Dependency: While international partnerships like Gavi, the Vaccine Alliance are vital, over-reliance creates unpredictability. Shifting donor priorities, complex application processes, and co-financing requirements disrupt planning and procurement, making countries like Kenya reactive, not proactive.
4. Weak Local Manufacturing: Africa produces less than 1% of the vaccines it uses, according to the Africa Centres for Disease Control and Prevention (Africa CDC). This lack of regional autonomy leaves the continent hostage to global supply chains and pricing structures, hindering rapid response to local needs and outbreaks. Initiatives like the African Vaccine Manufacturing Accelerator (AVMA), designed to boost production, remain critically underfunded.

Kenya’s Case: A System Under Strain

Kenya’s mid-2025 vaccine stockout crisis laid bare these structural flaws. Widespread shortages of BCG, Oral Polio, and MR vaccines, dwindling to less than two months’ supply nationally and collapsing entirely in a quarter of counties (Citizen Digital, Kenya News Agency, The East African), threatened to reverse decades of hard-won immunization progress. The immediate causes intertwined: delayed donor funding, procurement challenges, competing health priorities straining the budget, and the inherent fragility of a system reliant on external support. The Ministry of Health Kenya‘s response – reallocating emergency funds (Ministry of Health Kenya, Kenyans.co.ke) and initiating urgent national redistribution with partners like UNICEF to expedite deliveries – was commendably swift. Millions of Polio and BCG doses arrived by early June 2025 (The Star, Kenya, Kenyans.co.ke), averting immediate disaster. However, this was crisis management, not system resilience. It consumed scarce resources needed elsewhere and exposed the terrifying precarity of essential health services.

A Global Symptom

Kenya’s struggle is a microcosm. Stockouts and delays for routine vaccines plague numerous LMICs, eroding herd immunity and leaving populations vulnerable. The COVID-19 pandemic brutally exposed vaccine apartheid, but the inequity runs far deeper, affecting fundamental childhood immunizations. This is a direct failure against SDG 10.3 (ensure equal opportunity and reduce inequalities of outcome) and SDG 3.8 (achieve universal health coverage). When basic vaccines are inaccessible due to geography or economic status, health equity remains a distant dream.

Building Bridges: Towards Sustainable Vaccine Equity

We cannot keep relying on emergency bailouts. Concrete, systemic changes are imperative:

1. Sustainable Financing: LMICs must increase predictable domestic investment in health, particularly immunization. Donors must provide long-term, flexible funding aligned with national plans, moving beyond project-based cycles. Innovative financing mechanisms like health bonds or levies should be explored.
2. Bolster Local & Regional Manufacturing: Massive investment and technology transfer are crucial to build vaccine production capacity across Africa and other LMIC regions. Initiatives like AVMA must be fully funded and empowered. Diversified production enhances supply security and pandemic preparedness.
3. Strengthen Supply Chains & Procurement: Pooled procurement mechanisms like the Africa CDC‘s African Vaccine Acquisition Trust (AVATT) can increase bargaining power and predictability. Investments in last-mile delivery, cold chain infrastructure, and data systems are essential for efficiency.
4. Global Governance & Equity Frameworks: The World Health Organization (WHO) Pandemic Accord and International Health Regulations amendments must enshrine equitable access principles. Global vaccine distribution mechanisms for all vaccines need overhauling to prioritize need, not purchasing power.

Kenya’s empty vials are a warning. They signal the fragility of health security in the Global South and the persistent violation of the SDG promise to “leave no one behind.” Bridging the vaccine equity gap is not an act of charity; it is a fundamental requirement for global health security, justice, and the realization of SDGs 3 and 10. We must move beyond reactive crisis management and build resilient, equitable, and self-sustaining vaccine ecosystems. The health of children in Kenya, and billions across the Global South, depends on it. Justice delayed is immunity denied.